
Sermorelin
Synthetic analog of growth hormone-releasing hormone. The first 29 amino acids of the 44-amino-acid GHRH sequence.
Quantity
Bundle & Save
Research Use Only. This product is intended for laboratory research purposes only. Not for human or veterinary use. Not for sale to minors.
Sermorelin — Key Data
A snapshot of published research on Sermorelin. Each figure links to the literature summarized below.
How Sermorelin Works
Sermorelin is the first 29 amino acids of human GHRH, stimulating the pituitary to produce growth hormone in a physiological pulsatile pattern. Unlike exogenous HGH, it preserves the natural GH-IGF-1 feedback loop and self-limits via somatostatin. The earliest observable effects in clinical studies are improved sleep architecture, with body composition changes accelerating after 4-8 weeks. For research use only.
Discovered 1983200+ publicationsShortest fully functional synthetic fragment of human GHRH
- 01
GHRH Receptor Activation
Primary- Binds GHRH-R on pituitary somatotrophs
- Stimulates GH synthesis via cAMP-dependent signaling
- Preserves pulsatile release pattern (unlike exogenous HGH)
- 02
GH-IGF-1 Axis
Primary- IGF-1 elevated within 2 weeks (p<0.05)
- IGF-1 remained above baseline 2 weeks after stopping
- +1.26 kg lean body mass in men over 16 weeks
What the Studies Show
Peer-reviewed outcomes from published Sermorelin research.
0
Doubled 12-hour mean GH in 11 men aged 64-76 after 6 weeks of subcutaneous sermorelin.
Vittone et al., 1997Additional Clinical Outcomes
- 0Khorram et al., 1997
9 men aged 55-71 gained lean body mass over 16 weeks with no change in food intake or total body weight. Skin thickness also increased significantly.
- 0Corpas et al., 1992
All 10 elderly men responded with elevated GH. IGF-1 rose in a dose-response fashion approaching levels of younger men.
Sermorelin vs Exogenous HGH
Sermorelin self-limits via somatostatin feedback; HGH suppresses endogenous production
Research Applications
Reported areas of investigation across the Sermorelin literature.
- 01BODY COMPOSITION
Lean Mass and Skin Thickness
Men aged 55-71 gained 1.26 kg lean body mass over 16 weeks with no change in food intake or total body weight. Skin thickness also increased.
- Lean mass gain
- +1.26 kg
- Food intake change
- None
- Study duration
- 16 weeks
Study finding. Body composition changes without dietary modification suggest genuine GH axis restoration.
Khorram et al., 1997 - 02GH RESTORATION
Doubled Mean GH in Elderly
12-hour mean GH doubled in 11 men aged 64-76 after 6 weeks of subcutaneous sermorelin.
- GH increase
- 2x (12h mean)
- Age range
- 64-76 years
- Duration
- 6 weeks
Study finding. IGF-1 remained above baseline 2 weeks after stopping treatment.
Vittone et al., 1997 - 03SLEEP QUALITY
Improved Sleep Architecture
The earliest observable clinical effect of GH axis restoration is improved sleep architecture, preceding body composition changes.
- First effects
- Sleep improvement
- Body composition onset
- 4-8 weeks
Study finding. Clinical observation: improved deep sleep precedes measurable body composition changes by several weeks.
Reported Observations
- Self-limited by somatostatin feedback -- very low overdose risk
- Significantly fewer joint pain and fluid retention complaints vs exogenous HGH
- No significant changes in body weight, fat mass, or testosterone reported
This summary reflects observations from published peer-reviewed research. It is not a comprehensive safety assessment. Researchers should review primary literature before designing protocols. For Research Use Only.
Compound Profile
What Is Sermorelin?
Stability Information
- Protect from light
- Avoid repeated freeze-thaw cycles
- Store in original sealed container
Lyophilized (powder)
up to 2 years
Reconstituted
up to 30 days
Working solution
Use within 24 hours
References
Kemp & Frindik, 2007
These references are provided for informational purposes. Kern is not affiliated with the authors or institutions listed above.
Related Products
Important Notice — Please Read
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products we offer are not intended to diagnose, treat, cure, or prevent any disease. The peptides sold on this website are intended for research use only. The buyer is responsible for adhering to all local laws and regulations. Kern is not a pharmacy and does not provide medical advice or prescriptions. They are not for human consumption, are not FDA approved, and are not supplements or pharmaceutical drugs. The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please talk to your doctor. This site is an advertisement for education, research peptides, and not any specific medication. By purchasing from Kern, you confirm that you are a qualified researcher purchasing these compounds for legitimate in vitro or laboratory research purposes only. You must be 21 years of age or older to purchase.


